Developer docs
API playgroundTry for free, no card

Search company profiles

Sapyen

Full company profile

uuid0000qcu

Namestring
Sapyen
Legal namestring
Vito Health Pty Ltd
Websiteurl
sapyen.co
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Sapyen (legally Vito Health Pty Ltd, an Australian proprietary limited company) is a direct-to-consumer fertility diagnostics company that sells at-home male fertility test kits which are mailed to certified laboratories for analysis. Its product suite spans a Core Semen Analysis ($149), Antisperm Antibody Test ($229), DNA Fragmentation Test ($399), SpermEGT DNA Methylation Test ($529) integrating Path Fertility's SpermQT epigenetic assay, and a bundled Sapyen Complete Analysis ($869), plus Post-Vasectomy ($99) and Vasectomy Reversal tests and a Cryopreservation service. The core technical differentiator is its patent-pending SPX72 preservation fluid, which extends sperm sample viability to approximately 72 hours versus the industry standard of 60-90 minutes, enabling mail-in testing without sacrificing diagnostic accuracy.

The business operates a product-led DTC e-commerce model on its Shopify storefront across 25+ countries, supplemented by a B2B motion through referrals from IVF clinic networks (Genea, No.1 Fertility, IVIRMA, Adora Fertility, City Fertility) and employer fertility benefit integrations with Progyny, WIN Fertility, Maven Clinic and Carrot Fertility. Sapyen holds FDA, TGA, CE and MHRA registrations and operates through CLIA, UKAS, NATA and ISO 15189 accredited laboratories, with HIPAA, GDPR and Australian Privacy Act compliance. The company originated in Melbourne and expanded to the UK with an HFEA-licensed cryopreservation storage center.

Sapyen is privately held with no disclosed institutional funding beyond approximately $152,792 in early-stage capital from Antler and the Melbourne Accelerator Program. The customer base consists of men planning families, post-vasectomy patients, proactive fertility preservation users, couples undergoing fertility treatment, and healthcare professionals, served across North America, Europe, Asia-Pacific and the Middle East with multi-language instructions in 11 languages.

Short descriptiontext

Sapyen (Vito Health Pty Ltd) is an Australia-founded fertility diagnostics company that sells at-home male fertility test kits using its patent-pending SPX72 72-hour preservation fluid, shipping directly to consumers in 25+ countries and via IVF clinic referrals and employer fertility benefits.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersDover, United States
HQ citystring
Dover
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
at-home fertility testing, male fertility diagnostics, semen analysis kits, sperm cryopreservation services, fertility health platform
Industry2 codes
PRIMARYHLAAALAJ
Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening)
SECONDARYHLAMANAJ
Cryopreservation, Biobanking & Cell Banking (Cord/Adipose/MSC)
Healthcare & Life Sciences/Veterinary & Animal Health/Regenerative Medicine for Animals
NAICS code2 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Testing Laboratories and Services54138
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Commercial Physical & Biological Research8731
Product category
Fertility Diagnostics
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Direct Test Kit Sales
TypeOne Time License
Description

One-time purchase revenue from selling at-home male fertility test kits directly to consumers through the Sapyen e-commerce website. Products include Core Semen Analysis, DNA Fragmentation Test, Antisperm Antibody Test, SpermEGT DNA Methylation Test, Post-Vasectomy Semen Analysis, and Vasectomy Reversal tests.

sapyen.co
2Cryopreservation Services
TypeSubscription Recurring
Description

Sperm freezing and storage services offered as an add-on to test kits. Customers pay $1 for first year storage (90-day program) with 6-year storage terms. Revenue generated from the cryopreservation program enrollment and ongoing storage fees.

sapyen.co
3Employer Fertility Benefits
TypeTransaction Fee
Description

Partnerships with fertility benefit providers Progyny and WIN Fertility where eligible members receive test kits at $0 out-of-pocket cost. Sapyen processes authorization requests and ships kits, with reimbursement coming from employer benefit plans.

sapyen.co
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Marketing or Sales, Personnel, Technology or R&D, Infrastructure, Supply Chain
Pricing details8 tiers
1Core Semen Analysis - Entry-level fertility testing
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$149 USD - Measures sperm count, concentration, motility, and morphology. Includes 12 WHO-standard parameters. Results within 3 working days. $250 standard in-clinic cost comparison.

sapyen.co
2DNA Fragmentation Test - Advanced fertility assessment
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$399 USD - Includes Core Semen Analysis plus DNA Fragmentation Index testing. Reveals genetic integrity of sperm. $500 standard in-clinic cost. Results within 10 business days.

sapyen.co
3Antisperm Antibody Test - Immune-related infertility detection
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$229 USD - Core semen analysis plus antisperm antibody detection. Identifies antibodies that can halve fertilization rates. $300 standard in-clinic cost.

sapyen.co
4SpermEGT DNA Methylation Test - Epigenetic analysis
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$529 USD - Combines Core Semen Analysis with SpermQT epigenetic assay from Path Fertility. Assesses sperm DNA programming and functional quality. $700 standard in-clinic cost. Results within 3 weeks.

sapyen.co
5Sapyen Complete Analysis - Most comprehensive test
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$869 USD - Combines all core and advanced testing parameters into single kit. Includes semen analysis, DNA fragmentation, antisperm antibodies, and DNA methylation. $1,400 standard in-clinic cost.

sapyen.co
6Post-Vasectomy Semen Analysis
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$99 USD - Confirms vasectomy success by checking for remaining sperm. Recommended 12-16 weeks after surgery. $200 standard in-clinic cost. Results within 3 working days.

sapyen.co
7Vasectomy Reversal Test
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$149 USD - Checks if sperm has returned after vasectomy reversal surgery. Taken 6-8 weeks after procedure.

sapyen.co
8Cryopreservation Program
ModelSubscriptionBilling cadenceAnnual
Notes

$1 initial payment covers first full year of storage. 90-day program includes 2 semen collection kits, vitamins, infectious disease screening, and 6 years of storage. Refund if sample cannot be frozen.

sapyen.co
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 3 records shown
1SpermEGT
Description

Epigenetic sperm DNA methylation test using SpermQT assay from Path Fertility, measuring sperm's ability to find, bind, penetrate, and fertilize an egg

sapyen.co
+2 more records
Core offering1 text field

Sapyen sells at-home male fertility diagnostic kits and an associated sperm cryopreservation service that allow men to collect semen samples privately at home, preserve them for up to 72 hours via the company's patent-pending SPX72 fluid, and mail them to certified laboratories (CLIA, NATA, UKAS, ISO 15189) for clinical-grade analysis. The test menu includes the Core Semen Analysis ($149), Antisperm Antibody Test ($229), DNA Fragmentation Test ($399), SpermEGT DNA Methylation Test ($529, integrated with Path Fertility's SpermQT epigenetic assay), bundled Sapyen Complete Analysis ($869), Post-Vasectomy Semen Analysis ($99), and Vasectomy Reversal Test ($149). Sapyen also sells a 90-day Cryopreservation program ($1 first-year storage with 6-year term at -196°C) and a Full Female Blood Panel for couples testing.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 72-hour sample viability vs 60-90 minute industry standard
+3 more records
Product overview1 text field

Sapyen offers a suite of at-home male fertility diagnostic kits and services. The core product is the Core Semen Analysis kit ($149), which measures 12 sperm parameters including count, motility, morphology, and volume. Advanced add-on tests include the Antisperm Antibody Test ($229), DNA Fragmentation Test ($399), and SpermEGT DNA Methylation Test ($529). The Sapyen Complete Analysis ($869) bundles all tests into one comprehensive kit. Supporting services include Post Vasectomy Semen Analysis ($99), Vasectomy Reversal testing, and Sapyen Cryopreservation for sperm freezing ($1 first year storage). The company also offers a Full Female Blood Panel for couples testing. All tests use the proprietary patent-pending SPX72 preservation technology enabling 72-hour sample viability for mail-in testing.

Product and service10 records
1Core Semen Analysis (Sapyen At-Home Male Fertility Analysis Kit)
CategoryAt-Home Male Fertility Diagnostic Test
Description

At-home semen analysis kit measuring sperm count, concentration, motility, morphology, volume, and other key parameters via the WHO 2021 standard (12 parameters). Sample is collected at home, preserved using SPX72 fluid for up to 72 hours, mailed to a certified lab, and clinical-grade results returned within 72 hours of lab receipt. Priced at $149 USD versus typical $250–$400 in-clinic costs. Targets individual men planning a family or evaluating fertility.

2Antisperm Antibody Test (Advanced At-Home Male Fertility Analysis Kit)
CategoryAt-Home Male Fertility Diagnostic Test
Description

Enhanced analysis adding antisperm antibody testing to the core semen parameters. Antisperm antibodies can halve fertilization rates even with IVF/ICSI, making this test relevant for immune-related infertility workups. Priced at $229 USD versus typical $300 in-clinic cost. Marketed for men with unexplained infertility or IVF/ICSI failure history.

3DNA Fragmentation Test (Semen Analysis and DNA Fragmentation Test Kit)
CategoryAt-Home Male Fertility Diagnostic Test
Description

Core semen analysis combined with DNA Fragmentation Index testing to assess genetic integrity of sperm and reveal quality issues that impact conception and pregnancy outcomes even when standard semen parameters appear normal. Priced at $399 USD versus typical $500 in-clinic cost, with results within 10 business days. Targets couples with recurrent pregnancy loss or unexplained infertility.

4SpermEGT DNA Methylation Test
CategoryAt-Home Male Fertility Diagnostic Test
Description

Epigenetic assay combining Core Semen Analysis with the SpermQT epigenetic assay from Path Fertility, measuring sperm DNA programming and functional quality — including the sperm's ability to find, bind, penetrate, and fertilize an egg, as well as its impact on embryo health and pregnancy success. Priced at $529 USD versus typical $700 in-clinic cost, with results returned within 3 weeks.

5Sapyen Complete Analysis
CategoryAt-Home Male Fertility Diagnostic Test
Description

Most comprehensive at-home male fertility test, bundling all core and advanced parameters (semen analysis, antisperm antibodies, DNA fragmentation, and DNA methylation) into a single kit for the most complete picture of sperm health. Priced at $869 USD versus typical $1,400 in-clinic costs.

6Post Vasectomy Semen Analysis (PVSA)
CategoryAt-Home Male Fertility Diagnostic Test
Description

At-home test confirming vasectomy success by checking semen for the presence of sperm. Recommended 12–16 weeks after surgery and after at least 20 ejaculations. Priced at $99 USD versus typical $200 in-clinic cost, with results within 3 working days. Targets post-vasectomy patients seeking procedure confirmation.

7Vasectomy Reversal Test
CategoryAt-Home Male Fertility Diagnostic Test
Description

At-home semen analysis test taken 6–8 weeks after vasectomy reversal surgery to determine whether sperm has returned and whether it is healthy enough for conception. Priced at $149 USD.

8Sapyen Cryopreservation (Sperm Freezing)
CategorySperm Cryopreservation Service
Description

At-home sperm cryopreservation service preserving sperm at -196°C for up to 6 years. The 90-day program includes 2 semen collection kits, a vitamin protocol, infectious disease screening, and 6 years of storage at FDA-registered facility (US) or HFEA-licensed center (UK). Initial storage fee of $1 for the first year; standard in-clinic costs run ~$800. Refund provided if sample cannot be frozen. 7-day free cancellation offered. Targets men delaying parenthood, those about to undergo treatments affecting fertility, and gender-affirming care patients.

9Full Female Blood Panel
CategoryFemale Fertility Diagnostic Test
Description

Female fertility blood panel testing AMH, FSH, LH, estradiol, testosterone, and prolactin levels to assess female reproductive health. Pairs with Sapyen's male tests for couples fertility assessment. Targets the female partners in couples undergoing fertility evaluation.

10Couples At-Home Fertility Testing Suite
CategoryCouples Fertility Testing Suite
Description

Combined at-home fertility testing suite offering both Sapyen's male fertility tests (incorporating the Core Semen Analysis and SPX72-preserved lab semen analysis) and the Full Female Blood Panel for couples simultaneously. Aims to reduce delays in fertility assessment for couples in the UK market by enabling both partners to be evaluated at home in parallel.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership12 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Spermosens AB signed Memoranda of Understanding with Sapyen and RSI Technology Group to advance partner-driven commercialization of male fertility diagnostics in global markets. The partnership aims to advance Spermosens' JUNO-Checked male fertility diagnostic technology through Sapyen's distribution network.

Strategic tierCoreTypeTechnology or Integration
Description

Sapyen integrates Path Fertility's SpermQT epigenetic assay into its SpermEGT DNA Methylation Test, combining Sapyen's at-home collection and logistics with Path Fertility's specialized DNA methylation analysis technology.

Strategic tierCoreTypeGTM or Marketing Partner
Description

Leading Australian IVF clinic that refers patients to Sapyen and endorses the company's at-home testing services. Part of Sapyen's network of trusted clinic partners.

Strategic tierCoreTypeGTM or Marketing Partner
Description

Major fertility clinic network that recommends Sapyen testing to patients. Endorsed by clinic specialists including Eve Glage.

Strategic tierCoreTypeGTM or Marketing Partner
Description

Global IVF clinic group referring patients to Sapyen for at-home male fertility testing. One of the world's leading fertility treatment networks.

Strategic tierCoreTypeGTM or Marketing Partner
Description

Leading fertility benefit provider offering Sapyen tests at $0 cost to eligible members through employer benefit plans. Sapyen handles authorization and fulfillment for Progyny members.

Strategic tierCoreTypeGTM or Marketing Partner
Description

Fertility benefit provider enabling eligible WIN Fertility members to order Sapyen test kits at no cost. Sapyen processes authorizations and ships kits on behalf of WIN Fertility.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Fertility benefit provider where Sapyen customers can purchase tests and submit for reimbursement through Carrot's platform.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Fertility and family building benefit provider offering reimbursement for Sapyen tests. Customers purchase and submit invoices for reimbursement.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic institution collaborating on research and development of Sapyen's testing technology and methodology. Part of development team including experts and researchers.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic institution contributing to development of Sapyen's testing technology. Collaboration with fertility experts and researchers.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic institution involved in development of Sapyen's testing methodology. Contributes expertise from fertility researchers.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Legacy is a direct male fertility DTC company offering at-home sperm testing and cryopreservation, with a similar product-led go-to-market model and recurring storage revenue. Closely aligned business model, target customer, and product set as Sapyen.

2Dadi
TypeDirect peer
Description

Dadi offers at-home sperm testing and long-term storage with a kit + subscription model, competing in the same use cases (preconception testing and cryopreservation) and customer segments as Sapyen.

TypeDirect peer
Description

Fellow sells mail-in male fertility test kits with clinician-reviewed results and offers cryopreservation — overlapping head-to-head with Sapyen on product, customer (men planning families), and channel (DTC + clinician referrals).

TypeBroad incumbent
Description

Maven is a leading family-building benefit provider; comparable to Sapyen in that it channels beneficiaries toward male fertility solutions and is also a Sapyen distribution partner, representing an incumbent in the fertility benefit category.

TypeDirect peer
Description

YO is an FDA-cleared at-home male fertility test kit with smartphone-based motility analysis — same at-home, direct-to-consumer sperm testing category that Sapyen competes in.

TypeDirect peer
Description

ExSeed provides at-home sperm analysis kits and lifestyle-focused male fertility programs in Europe; directly comparable as a mail-in semen analysis service targeting men trying to conceive.

TypeBroad incumbent
Description

Progyny is a fertility benefit management incumbent that integrates with Sapyen for $0-copay male testing — comparable as the dominant employer-channel beneficiary of male fertility diagnostics and a key Sapyen channel partner.

TypeBroad incumbent
Description

Carrot is a global fertility benefit provider serving employers; comparable as a dominant incumbent in the channel through which male fertility products (including Sapyen's) are distributed and reimbursed.

TypeRegional player
Description

Genea Biomedx develops fertility lab diagnostics and IVF lab technologies, primarily APAC-focused; comparable as a fertility diagnostics adjacent player closely tied to the same clinician network (Genea) that partners with Sapyen.

10Ro (Roman)
TypeBroad incumbent
Description

Ro is a broader men's and women's health platform with a fertility vertical offering sperm testing and treatments — comparable because it serves the same customer intent (male fertility evaluation) but as part of a much wider telehealth portfolio.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance11 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sapyen

Fertility Diagnosticssapyen.co

Sapyen (Vito Health Pty Ltd) is an Australia-founded fertility diagnostics company that sells at-home male fertility test kits using its patent-pending SPX72 72-hour preservation fluid, shipping directly to consumers in 25+ countries and via IVF clinic referrals and employer fertility benefits.

What Sapyen does

Sapyen (legally Vito Health Pty Ltd, an Australian proprietary limited company) is a direct-to-consumer fertility diagnostics company that sells at-home male fertility test kits which are mailed to certified laboratories for analysis. Its product suite spans a Core Semen Analysis ($149), Antisperm Antibody Test ($229), DNA Fragmentation Test ($399), SpermEGT DNA Methylation Test ($529) integrating Path Fertility's SpermQT epigenetic assay, and a bundled Sapyen Complete Analysis ($869), plus Post-Vasectomy ($99) and Vasectomy Reversal tests and a Cryopreservation service. The core technical differentiator is its patent-pending SPX72 preservation fluid, which extends sperm sample viability to approximately 72 hours versus the industry standard of 60-90 minutes, enabling mail-in testing without sacrificing diagnostic accuracy.

The business operates a product-led DTC e-commerce model on its Shopify storefront across 25+ countries, supplemented by a B2B motion through referrals from IVF clinic networks (Genea, No.1 Fertility, IVIRMA, Adora Fertility, City Fertility) and employer fertility benefit integrations with Progyny, WIN Fertility, Maven Clinic and Carrot Fertility. Sapyen holds FDA, TGA, CE and MHRA registrations and operates through CLIA, UKAS, NATA and ISO 15189 accredited laboratories, with HIPAA, GDPR and Australian Privacy Act compliance. The company originated in Melbourne and expanded to the UK with an HFEA-licensed cryopreservation storage center.

Sapyen is privately held with no disclosed institutional funding beyond approximately $152,792 in early-stage capital from Antler and the Melbourne Accelerator Program. The customer base consists of men planning families, post-vasectomy patients, proactive fertility preservation users, couples undergoing fertility treatment, and healthcare professionals, served across North America, Europe, Asia-Pacific and the Middle East with multi-language instructions in 11 languages.

Sapyen firmographics

Firmographics
Name
Sapyen
Legal name
Vito Health Pty Ltd
Website
https://sapyen.co
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
Sapyen (Vito Health Pty Ltd) is an Australia-founded fertility diagnostics company that sells at-home male fertility test kits using its patent-pending SPX72 72-hour preservation fluid, shipping directly to consumers in 25+ countries and via IVF clinic referrals and employer fertility benefits.
Ownership category
akta.pro rank

Sapyen industry classification

Industry
Product category
Fertility Diagnostics
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Testing Laboratories and Services (54138)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAAALAJ
Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening)
SECONDARYHLAMANAJ
Cryopreservation, Biobanking & Cell Banking (Cord/Adipose/MSC)
Healthcare & Life Sciences/Veterinary & Animal Health/Regenerative Medicine for Animals

Keywords

  • At-home fertility testing
  • Male fertility diagnostics
  • Semen analysis kits
  • Sperm cryopreservation services
  • Fertility health platform

Where Sapyen is headquartered

Location

Headquarters

HQ city
Dover
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Sapyen business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Operations, Marketing or Sales, Personnel, Technology or R&D, Infrastructure, Supply Chain

Revenue model

  1. Direct Test Kit Sales: One-time purchase revenue from selling at-home male fertility test kits directly to consumers through the Sapyen e-commerce website. Products include Core Semen Analysis, DNA Fragmentation Test, Antisperm Antibody Test, SpermEGT DNA Methylation Test, Post-Vasectomy Semen Analysis, and Vasectomy Reversal tests.
  2. Cryopreservation Services: Sperm freezing and storage services offered as an add-on to test kits. Customers pay $1 for first year storage (90-day program) with 6-year storage terms. Revenue generated from the cryopreservation program enrollment and ongoing storage fees.
  3. Employer Fertility Benefits: Partnerships with fertility benefit providers Progyny and WIN Fertility where eligible members receive test kits at $0 out-of-pocket cost. Sapyen processes authorization requests and ships kits, with reimbursement coming from employer benefit plans.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goCore Semen Analysis - Entry-level fertility testing
Unit PricingPay-as-you-goDNA Fragmentation Test - Advanced fertility assessment
Unit PricingPay-as-you-goAntisperm Antibody Test - Immune-related infertility detection
Unit PricingPay-as-you-goSpermEGT DNA Methylation Test - Epigenetic analysis
Unit PricingPay-as-you-goSapyen Complete Analysis - Most comprehensive test
Unit PricingPay-as-you-goPost-Vasectomy Semen Analysis
Unit PricingPay-as-you-goVasectomy Reversal Test
SubscriptionAnnualCryopreservation Program

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Sapyen product offering

Product offering

Core offering

Sapyen sells at-home male fertility diagnostic kits and an associated sperm cryopreservation service that allow men to collect semen samples privately at home, preserve them for up to 72 hours via the company's patent-pending SPX72 fluid, and mail them to certified laboratories (CLIA, NATA, UKAS, ISO 15189) for clinical-grade analysis. The test menu includes the Core Semen Analysis ($149), Antisperm Antibody Test ($229), DNA Fragmentation Test ($399), SpermEGT DNA Methylation Test ($529, integrated with Path Fertility's SpermQT epigenetic assay), bundled Sapyen Complete Analysis ($869), Post-Vasectomy Semen Analysis ($99), and Vasectomy Reversal Test ($149). Sapyen also sells a 90-day Cryopreservation program ($1 first-year storage with 6-year term at -196°C) and a Full Female Blood Panel for couples testing.

Product overview

Sapyen offers a suite of at-home male fertility diagnostic kits and services. The core product is the Core Semen Analysis kit ($149), which measures 12 sperm parameters including count, motility, morphology, and volume. Advanced add-on tests include the Antisperm Antibody Test ($229), DNA Fragmentation Test ($399), and SpermEGT DNA Methylation Test ($529). The Sapyen Complete Analysis ($869) bundles all tests into one comprehensive kit. Supporting services include Post Vasectomy Semen Analysis ($99), Vasectomy Reversal testing, and Sapyen Cryopreservation for sperm freezing ($1 first year storage). The company also offers a Full Female Blood Panel for couples testing. All tests use the proprietary patent-pending SPX72 preservation technology enabling 72-hour sample viability for mail-in testing.

Differentiator

Problem solved

Functional benefit

Brands

  • SpermEGT: Epigenetic sperm DNA methylation test using SpermQT assay from Path Fertility, measuring sperm's ability to find, bind, penetrate, and fertilize an egg
  • Sapyen Complete Analysis
  • SPX72

Products and services

  • Core Semen Analysis (Sapyen At-Home Male Fertility Analysis Kit) At-home semen analysis kit measuring sperm count, concentration, motility, morphology, volume, and other key parameters via the WHO 2021 standard (12 parameters). Sample is collected at home, preserved using SPX72 fluid for up to 72 hours, mailed to a certified lab, and clinical-grade results returned within 72 hours of lab receipt. Priced at $149 USD versus typical $250–$400 in-clinic costs. Targets individual men planning a family or evaluating fertility.
  • Antisperm Antibody Test (Advanced At-Home Male Fertility Analysis Kit) Enhanced analysis adding antisperm antibody testing to the core semen parameters. Antisperm antibodies can halve fertilization rates even with IVF/ICSI, making this test relevant for immune-related infertility workups. Priced at $229 USD versus typical $300 in-clinic cost. Marketed for men with unexplained infertility or IVF/ICSI failure history.
  • DNA Fragmentation Test (Semen Analysis and DNA Fragmentation Test Kit) Core semen analysis combined with DNA Fragmentation Index testing to assess genetic integrity of sperm and reveal quality issues that impact conception and pregnancy outcomes even when standard semen parameters appear normal. Priced at $399 USD versus typical $500 in-clinic cost, with results within 10 business days. Targets couples with recurrent pregnancy loss or unexplained infertility.
  • SpermEGT DNA Methylation Test Epigenetic assay combining Core Semen Analysis with the SpermQT epigenetic assay from Path Fertility, measuring sperm DNA programming and functional quality — including the sperm's ability to find, bind, penetrate, and fertilize an egg, as well as its impact on embryo health and pregnancy success. Priced at $529 USD versus typical $700 in-clinic cost, with results returned within 3 weeks.
  • Sapyen Complete Analysis Most comprehensive at-home male fertility test, bundling all core and advanced parameters (semen analysis, antisperm antibodies, DNA fragmentation, and DNA methylation) into a single kit for the most complete picture of sperm health. Priced at $869 USD versus typical $1,400 in-clinic costs.
  • Post Vasectomy Semen Analysis (PVSA) At-home test confirming vasectomy success by checking semen for the presence of sperm. Recommended 12–16 weeks after surgery and after at least 20 ejaculations. Priced at $99 USD versus typical $200 in-clinic cost, with results within 3 working days. Targets post-vasectomy patients seeking procedure confirmation.
  • Vasectomy Reversal Test At-home semen analysis test taken 6–8 weeks after vasectomy reversal surgery to determine whether sperm has returned and whether it is healthy enough for conception. Priced at $149 USD.
  • Sapyen Cryopreservation (Sperm Freezing) At-home sperm cryopreservation service preserving sperm at -196°C for up to 6 years. The 90-day program includes 2 semen collection kits, a vitamin protocol, infectious disease screening, and 6 years of storage at FDA-registered facility (US) or HFEA-licensed center (UK). Initial storage fee of $1 for the first year; standard in-clinic costs run ~$800. Refund provided if sample cannot be frozen. 7-day free cancellation offered. Targets men delaying parenthood, those about to undergo treatments affecting fertility, and gender-affirming care patients.
  • Full Female Blood Panel Female fertility blood panel testing AMH, FSH, LH, estradiol, testosterone, and prolactin levels to assess female reproductive health. Pairs with Sapyen's male tests for couples fertility assessment. Targets the female partners in couples undergoing fertility evaluation.
  • Couples At-Home Fertility Testing Suite Combined at-home fertility testing suite offering both Sapyen's male fertility tests (incorporating the Core Semen Analysis and SPX72-preserved lab semen analysis) and the Full Female Blood Panel for couples simultaneously. Aims to reduce delays in fertility assessment for couples in the UK market by enabling both partners to be evaluated at home in parallel.

Quantifiable outcome

  • 72-hour sample viability vs 60-90 minute industry standard
  • +3 more outcomes

Companies that use Sapyen

Customer profile

Named customers10 records

Segments5 records

Ideal customer profiles3 records

Sapyen technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability1 record

Feature3 records

Sapyen partnerships and signals

Strategic signal

Partnerships

Twelve partnerships are on record, tiered minor and core.

  • Spermosens ABminorStrategic or Co-development Partner · 1 January 2025Spermosens AB signed Memoranda of Understanding with Sapyen and RSI Technology Group to advance partner-driven commercialization of male fertility diagnostics in global markets. The partnership aims to advance Spermosens' JUNO-Checked male fertility diagnostic technology through Sapyen's distribution network.
  • Path FertilitycoreTechnology or IntegrationSapyen integrates Path Fertility's SpermQT epigenetic assay into its SpermEGT DNA Methylation Test, combining Sapyen's at-home collection and logistics with Path Fertility's specialized DNA methylation analysis technology.
  • GeneacoreGTM or Marketing PartnerLeading Australian IVF clinic that refers patients to Sapyen and endorses the company's at-home testing services. Part of Sapyen's network of trusted clinic partners.
  • No.1 FertilitycoreGTM or Marketing PartnerMajor fertility clinic network that recommends Sapyen testing to patients. Endorsed by clinic specialists including Eve Glage.
  • IVIRMAcoreGTM or Marketing PartnerGlobal IVF clinic group referring patients to Sapyen for at-home male fertility testing. One of the world's leading fertility treatment networks.
  • ProgynycoreGTM or Marketing PartnerLeading fertility benefit provider offering Sapyen tests at $0 cost to eligible members through employer benefit plans. Sapyen handles authorization and fulfillment for Progyny members.
  • WIN FertilitycoreGTM or Marketing PartnerFertility benefit provider enabling eligible WIN Fertility members to order Sapyen test kits at no cost. Sapyen processes authorizations and ships kits on behalf of WIN Fertility.
  • Carrot FertilityminorGTM or Marketing PartnerFertility benefit provider where Sapyen customers can purchase tests and submit for reimbursement through Carrot's platform.
  • Maven ClinicminorGTM or Marketing PartnerFertility and family building benefit provider offering reimbursement for Sapyen tests. Customers purchase and submit invoices for reimbursement.
  • Oxford UniversityminorStrategic or Co-development PartnerAcademic institution collaborating on research and development of Sapyen's testing technology and methodology. Part of development team including experts and researchers.
  • Harvard UniversityminorStrategic or Co-development PartnerAcademic institution contributing to development of Sapyen's testing technology. Collaboration with fertility experts and researchers.
  • Stanford UniversityminorStrategic or Co-development PartnerAcademic institution involved in development of Sapyen's testing methodology. Contributes expertise from fertility researchers.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Sapyen competitors and assessment

Company assessment

Direct peers

  • Legacy: Legacy is a direct male fertility DTC company offering at-home sperm testing and cryopreservation, with a similar product-led go-to-market model and recurring storage revenue. Closely aligned business model, target customer, and product set as Sapyen.
  • Dadi: Dadi offers at-home sperm testing and long-term storage with a kit + subscription model, competing in the same use cases (preconception testing and cryopreservation) and customer segments as Sapyen.
  • Fellow: Fellow sells mail-in male fertility test kits with clinician-reviewed results and offers cryopreservation — overlapping head-to-head with Sapyen on product, customer (men planning families), and channel (DTC + clinician referrals).
  • YO Home Sperm Test: YO is an FDA-cleared at-home male fertility test kit with smartphone-based motility analysis — same at-home, direct-to-consumer sperm testing category that Sapyen competes in.
  • ExSeed Health: ExSeed provides at-home sperm analysis kits and lifestyle-focused male fertility programs in Europe; directly comparable as a mail-in semen analysis service targeting men trying to conceive.

Broad incumbents

  • Maven Clinic: Maven is a leading family-building benefit provider; comparable to Sapyen in that it channels beneficiaries toward male fertility solutions and is also a Sapyen distribution partner, representing an incumbent in the fertility benefit category.
  • Progyny: Progyny is a fertility benefit management incumbent that integrates with Sapyen for $0-copay male testing — comparable as the dominant employer-channel beneficiary of male fertility diagnostics and a key Sapyen channel partner.
  • Carrot Fertility: Carrot is a global fertility benefit provider serving employers; comparable as a dominant incumbent in the channel through which male fertility products (including Sapyen's) are distributed and reimbursed.
  • Ro (Roman): Ro is a broader men's and women's health platform with a fertility vertical offering sperm testing and treatments — comparable because it serves the same customer intent (male fertility evaluation) but as part of a much wider telehealth portfolio.

Regional players

  • Genea Biomedx: Genea Biomedx develops fertility lab diagnostics and IVF lab technologies, primarily APAC-focused; comparable as a fertility diagnostics adjacent player closely tied to the same clinician network (Genea) that partners with Sapyen.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Sapyen social profiles

Digital presence

Sapyen compliance and trust

Trust signal

Compliance11 records

Sapyen financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sapyen leadership team

Management profile

Number of profiles

Sapyen funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sapyen M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sapyen

What does Sapyen do?

Sapyen sells at-home male fertility diagnostic kits and an associated sperm cryopreservation service that allow men to collect semen samples privately at home, preserve them for up to 72 hours via the company's patent-pending SPX72 fluid, and mail them to certified laboratories (CLIA, NATA, UKAS, ISO 15189) for clinical-grade analysis. The test menu includes the Core Semen Analysis ($149), Antisperm Antibody Test ($229), DNA Fragmentation Test ($399), SpermEGT DNA Methylation Test ($529, integrated with Path Fertility's SpermQT epigenetic assay), bundled Sapyen Complete Analysis ($869), Post-Vasectomy Semen Analysis ($99), and Vasectomy Reversal Test ($149). Sapyen also sells a 90-day Cryopreservation program ($1 first-year storage with 6-year term at -196°C) and a Full Female Blood Panel for couples testing.

Is Sapyen a public or private company?

Sapyen is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Sapyen founded?

Sapyen was founded in 2021. It employs 11 to 50 people.

Where is Sapyen based?

Sapyen is headquartered in Dover, United States, in the North America region.

How does Sapyen make money?

Three revenue lines are on record. Direct Test Kit Sales are the primary driver. The others are cryopreservation Services and employer Fertility Benefits.

Who are Sapyen's main competitors?

Direct peers on record are Legacy, Dadi, Fellow, YO Home Sperm Test and ExSeed Health. Broad incumbents are Maven Clinic, Progyny, Carrot Fertility and Ro (Roman). Genea Biomedx is listed as a regional player.

Does Sapyen have an API?

No public API is recorded for Sapyen.

What industry is Sapyen in?

Sapyen's product category is Fertility Diagnostics. Its primary akta.pro industry code is HLAAALAJ, Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening), with a secondary code of HLAMANAJ, Cryopreservation, Biobanking & Cell Banking (Cord/Adipose/MSC). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireSapyen and MSI Australia Partner to Make Post-Vasectomy Testing More AccessibleSapyen and MSI Australia partnered to let MSI vasectomy clients complete post-vasectomy semen analysis at home using Sapyen's test kit. Up to 45% of Australian men do not complete recommended PVSA, and the partnership aims to improve completion rates. The collaboration expands Sapyen's at-home diagnostics beyond fertility assessment.FinancialContent Business PageSapyen and IVF London Announce Strategic Partnership to Expand Access to Home Male Fertility Diagnostics Across The UKSapyen and IVF London announced a strategic partnership to expand access to home-based male fertility diagnostics across the United Kingdom, with Sapyen becoming IVF London's exclusive provider of mail-in semen analysis kits. The partnership enables patients to complete semen analysis from home while remaining connected to IVF London's clinical pathway, aiming to accelerate earlier male fertility assessment and encourage greater male participation in fertility care. The collaboration reflects a broader shift toward home-based diagnostics in reproductive healthcare, combining IVF London's clinical expertise with Sapyen's home diagnostics platform.FinancialContent Business PageSapyen and IVF London announce strategic partnership to expand access to home male fertility diagnostics across the UKSapyen and IVF London have announced a strategic partnership to expand access to home-based male fertility diagnostics across the United Kingdom, with Sapyen becoming IVF London's exclusive provider of mail-in semen analysis kits. The collaboration enables patients referred through IVF London to complete mail-in semen analysis from home, with laboratory analysis through the Sapyen-IVF London pathway, aiming to support earlier clinical decision-making and greater male participation in fertility care. The partnership reflects a broader evolution in reproductive healthcare as fertility providers increasingly explore home-based diagnostics to improve access and accelerate assessment.Business InsiderSapyen and IVF London announce strategic partnership to expand access to home male fertility diagnostics across the UKSapyen and IVF London have announced a strategic partnership making Sapyen the exclusive provider of mail-in semen analysis kits for home-based male fertility diagnostics across the United Kingdom. The collaboration enables patients referred through IVF London to complete semen analysis from home, with laboratory analysis through the agreed clinical pathway and results supporting clinical review. The partnership includes a framework for service innovation, education, and potential future collaboration in male reproductive healthcare, subject to appropriate clinical, operational, and commercial approvals.NewsfileSapyen Launches Sperm Freezing Service for 1 PoundSapyen launched a UK sperm freezing service at £1 for the first year, combining at-home analysis with a 90-day optimisation protocol. The company aims to make fertility preservation proactive rather than reactive, targeting men delaying parenthood and IVF patients.YahooSapyen Bundles At-Home Fertility Hormone Testing for Couples to Cut Delays in HealthcareSapyen, a fertility diagnostics company, has launched an at-home testing suite for couples in the UK, combining male and female fertility tests with laboratory semen analysis. This new approach aims to reduce delays in fertility assessment and improve the accuracy and speed of diagnosis.YahooSapyen Launches UK's First At-Home Male Fertility TestSapyen has launched the UK's first at-home male fertility testing kit, enabling men to collect samples at home and send them to a laboratory for analysis, with results delivered within days. The kit addresses delays in NHS fertility pathways where research indicates one in four men undergoing IVF are never tested at the outset, often leading to women undergoing costly procedures before male fertility issues are identified. Sapyen's proprietary SPX72 medium preserves sperm viability for up to 72 hours during transit, supporting the company's expansion into the UK market from its Melbourne, Australia base.GlobeNewswireARC Fertility and Sapyen Announce Strategic Partnership to Revolutionize Male Fertility Testing, Expanding Reproductive Health Benefits for Employers and WorkforcesARC Fertility and Sapyen announced a strategic partnership to offer at-home male fertility testing to employers and employees. The Sapyen test kit costs $149 and includes a sperm stabilization medium, with 50% of fertility issues being male-related. The collaboration aims to make fertility care more accessible and support DEI and ESG initiatives.GlobeNewswireARC Fertility and Sapyen Announce Strategic Partnership to Revolutionize Male Fertility Testing, Expanding Reproductive Health Benefits for Employers and WorkforcesARC Fertility and Sapyen announced a partnership to offer at-home male fertility testing to employers and employees. The Sapyen test kit costs $149 and includes a sperm stabilization medium, with 50% of fertility issues being male-related. The collaboration aims to make fertility care more accessible and align with DEI and ESG goals.ABCHow Ashwin's uncle's $130,000 IVF journey inspired him to start a company to help infertile menAshwin Ramachandran, after his uncle spent $130,000 on IVF in the US, founded Sapyen in 2021 to develop an at-home semen testing kit. The kit uses a stabilization medium to preserve samples for three days, addressing the one-hour collection limit. He also aims to reduce stigma around male infertility in Asian countries.